Jazz Pharmaceuticals gets FDA approval for cancer therapy
June 17, 2020 at 12:33 PM EDT
Jazz, which has offices in Philadelphia and Palo Alto, licensed the U.S. marketing rights for the small cell lung cancer treatment in January.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|